Fashion
Airasia received the highest number of approvals from the Malaysian Aviation Commission (Mavcom) for Air Traffic Rights (ATR) with 26 allocations, followed by Malindo Air with 15 allocations.
This was revealed in an update release from Mavcom for the Commissions’ allocation of ATR to Malaysia’s local carriers for the period of Jan 1 to march 31, 2019.
One hundred percent of Air Traffic Rights (ATR) applications by Malaysia’s local carriers for the period of Jan 1 to March 31, 2019 were approved by MAVCOM, with 53 allocations in total. Of these, 52 ATR applications were approved in full while one application was approved partially.
As reference, for the year 2018, a total of 205 ATR were issued. AirAsia Group was recorded as the highest recipient with 98 ATR allocated, followed by Malindo Air with 52.
Of the 53 applications, 32.1 per cent were for domestic routes while 67.9 per cent was for international routes. Mavcom approved ATRs for 17 domestic routes, 13 for routes to Asean destinations, 11 for destinations in China, two for destinations in India, five for destinations in Australasia and five for other Asian destinations.
Breaking down the numbers further, a total of 26 international ATR were issued for flights originating from Kuala Lumpur International Airport, three for Kota Kinabalu International
Airport, one each for Penang International Airport and Senai International Airport and five for other airports in Malaysia.
In addition, 20 ATR that were previously approved by Mavcom were not utilised by the ATR recipient and were returned to the Commission during the period of Jan 1 to March 31, 2019.
The highest number of unused ATR returned to the Commission was from the AirAsia Group with 13, followed by Malindo Air with five.
“In allocating ATR, the Commission undertakes a thorough analysis, taking into consideration multiple aspects in order to facilitate orderly growth, competition and consumer choice over the long term as well as the prevention of consumer inconvenience,” Mavcom executive chairman Dr. Nungsari Ahmad Radhi said in a statement.
